Research on the cardiovascular function evaluation system based on noninvasive detection indices_Journal of Biomedical Engineering

Authors：

SONG Xiaorui ¹ , LI Gaoyang ² , WANG Xuezheng ¹ , WANG Shigang ¹ , FAN Xiangming ³ , YANG Yao ³ ,  QIAO Aike ⁴

1. Department of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R.China;
2. Graduate School of Biomedical Engineering, Tohoku University, Sendai 9808577, Japan;
3. Surgrey of Pediatric Heart Center, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, P.R.China;
4. College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, P.R.China;

Corresponding author：

QIAO Aike, Email: qak@bjut.edu.cn

Keywords：

noninvasive detection; analytic hierarchy process; fuzzy mathematics; health assessment

DOI：

10.7507/1001-5515.201807064

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Based on the noninvasive detection indeices and fuzzy mathematics method, this paper studied the noninvasive, convenient and economical cardiovascular health assessment system. The health evaluation index of cardiovascular function was built based on the internationally recognized risk factors of cardiovascular disease and the noninvasive detection index. The weight of 12 indexes was completed by the analytic hierarchy process, and the consistency test was passed. The membership function, evaluation matrix and evaluation model were built by fuzzy mathematics. The introducted methods enhanced the scientificity of the evaluation system. Through the Kappa consistency test, McNemer statistical results (P = 0.995 > 0.05) and Kappa values (Kappa = 0.616, P < 0.001) suggest that the comprehensive evaluation results of model in this paper are relatively consistent with the clinical, which is of certain scientific significance for the early detection of cardiovascular diseases.

Citation： SONG Xiaorui, LI Gaoyang, WANG Xuezheng, WANG Shigang, FAN Xiangming, YANG Yao, QIAO Aike. Research on the cardiovascular function evaluation system based on noninvasive detection indices. Journal of Biomedical Engineering, 2019, 36(4): 649-656. doi: 10.7507/1001-5515.201807064 Copy

1.	Su T C, Chen S Y, Chan C C. Progress of ambient air pollution and cardiovascular disease research in Asia. Prog Cardiovasc Dis, 2011, 53(5): 369-378.
2.	Parissis J T, Nikolaou M, Farmakis D A, et al. Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail, 2009, 11(2): 163-169.
3.	Chryssanthopoulos S N, Dritsas A, Cokkinos D V. Activity questionnaires; a useful tool in accessing heart failure patients. Int J Cardiol, 2005, 105(3): 294-299.
4.	Faller H, Steinbüchel T, Störk S, et al. Impact of depression on quality of life assessment in heart failure. Int J Cardiol, 2010, 142(2): 133-137.
5.	Guyatt G H. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol, 1993, 22(4): A185-A191.
6.	梁国才, 张卫. 美国心血管医学现在和未来. 上海预防医学, 1997, 9(8): 353-355.
7.	Rankin S L, Briffa T G, Morton A R, et al. A specific activity questionnaire to measure the functional capacity off cardiac patients. Am J Cardiol, 1996, 77(14): 1220-1223.
8.	Mittelmark M B, Psaty B M, Rautaharju P M, et al. Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol, 1993, 137(3): 311-317.
9.	Booth G L, Kapral M K, Fung K, et al. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet, 2006, 368(9529): 29-36.
10.	Bazzano L A, Gu Dongfeng, Whelton M R, et al. Body mass index and risk of stroke among Chinese men and women. Ann Neurol, 2010, 67(1): 11-20.
11.	Lanas F, Avezum A, Bautista L E, et al. Risk factors for acute myocardial infarction in Latin America. Circulation, 2007, 115(9): 1067-1074.
12.	Wang Hongwei, Cao Jie, Li Jianxin, et al. Blood pressure, body mass index and risk of cardiovascular disease in Chinese men and women. BMC Public Health, 2010, 10(1): 189.
13.	Chobanian A V, Bakris G L, Black H R, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Acc Curr J Rev, 2003, 12(3): 31-32.
14.	Magdás A, Benedek I, Belényi B, et al. The relationship between blood pressure variability and cardiovascular risk factors in patients with primary hypertension. Acta Medica Marisiensis, 2015, 61(1): 31-33.
15.	Chowdhury E K, Owen A, Krum H, et al. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens, 2014, 32(3): 525-533.
16.	Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy novelty and significance. Hypertension, 2014, 64(5): 989-996.
17.	Gordon D J, Probstfield J L, Garrison R J, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 1989, 79(1): 8-15.
18.	Bai Yuntao, Sun Qinghua. Fine particulate matter air pollution and atherosclerosis: Mechanistic insights. Biochimica et Biophysica Acta-General Subjects, 2016, 1860(12, SI): 2863-2868.
19.	Yang Wenying, Lu Juming, Weng Jianping, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12): 1090-1101.
20.	Akhuemonkhan E, Lazo M. Association between family history of diabetes and cardiovascular disease and lifestyle risk factors in the United States population: The 2009-2012 National Health and Nutrition Examination Survey. Prev Med, 2017, 96: 129-134.
21.	Cordero A, Alegria E. Sex differences and cardiovascular risk. Heart, 2006, 92(2): 145-146.
22.	Taylor M K, Larson G E, Lauby M D H, et al. Sex differences in cardiovascular and subjective stress reactions: prospective evidence in a realistic military setting. Stress, 2014, 17(1): 70-78.
23.	Reynolds K, Lewis B, Nolen J D, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA, 2003, 289(5): 579-588.
24.	Bazzano L A, Gu Dongfeng, Reynolds K, et al. Alcohol consumption and risk for stroke among Chinese men. Ann Neurol, 2007, 62(6): 569-578.
25.	Chen Wei. Relationship between smoking and cardiovascular disease mortality, all-cause mortality in hypertension patients: a prospective cohort study. Pract J Cardiac Cerebr Pneum Vasc Dis, 2015, 23(11): 5-9.
26.	Jia G X, Yu J M, Lin F L, et al. The relationship between smoking status and cardiovascular risk stratification in hypertensive patients. Chin J Hypertens, 2013, 21(4): 340-345.
27.	Gu Dongfeng, Kelly T N, WU Xigui, et al. Mortality attributable to smoking in China. N Engl J Med, 2009, 360(2): 150-159.
28.	李迅. 心血管危险因素控制和心血管病的预防. 中西医结合心血管病电子杂志, 2015, 3(2): 130-131.
29.	Vornanen M, Konttinen H, Kääriäinen H, et al. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression. Prev Med, 2016, 90: 177-183.
30.	Shao G H, Zhang R L. Study of sports and health guidelines for graduate students. J Wuhan Institute of Physical Education, 2005, 39(9): 61-64.
31.	王国军. 健康管理理念下公务员体质健康评价系统的研究与应用. 上海: 上海体育学院, 2013.
32.	Wang Bing, Xie Hongli, Ren Hongyang, et al. Application of AHP, TOPSIS, and TFNs to plant selection for phytoremediation of petroleum-contaminated soils in shale gas and oil fields. J Clean Prod, 2019, 233: 13-22.
33.	Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the managementof arterial hypertension. Eur Heart J, 2018, 39: 3021-3104.
34.	Weber M A, Schiffrin E L, White W B, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens, 2014, 32(1): 3-15.
35.	Clark C E, Taylor R S, Shore A C, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet, 2012, 379(9819): 905-914.
36.	Clark C E, Taylor R S, Shore A C, et al. Interarm blood pressure difference and vascular disease–authors'reply. Lancet, 2012, 380(9836): 24-25.
37.	Cao Kaiwu, Xu Jingsong, Qing Shangguan, et al. Association of an inter-arm systolic blood pressure difference with all-cause and cardiovascular mortality: An updated meta-analysis of cohort studies. Int J Cardiol, 2015, 189: 211-219.
38.	Clark C E, Campbell J L, Powell R J. The interarm blood pressure difference as predictor of cardiovascular events in patients with hypertension in primary care: cohort study. J Hum Hypertens, 2007, 21(8): 633-638.
39.	Sheng C S, Liu M, Zeng W F, et al. Four-limb blood pressure as predictors of mortality in elderly Chinese novelty and significance. Hypertension, 2013, 61(6): 1155-1160.
40.	Chen S C, Chang J M, Tsai Y C, et al. Association of interleg BP difference with overall and cardiovascular mortality in hemodialysis. Clin J Am Soc Nephrol, 2012, 7(10): 1646-1653.
41.	Su H M, Lin T H, Hsu P C, et al. Association of interankle systolic blood pressure difference with peripheral vascular disease and left ventricular mass index. Am J Hypertens, 2014, 27(1): 32-37.
42.	Clark C E, Campbell J L, Powell R J, et al. The interarm blood pressure difference and peripheral vascular disease: cross-sectional study. Fam Pract, 2007, 24(5): 420-426.
43.	Cao Kaiwu, Xu Jinsong, Sun Hanjun, et al. The variability of ankle-arm blood pressure difference and ankle-brachial index in treated hypertensive patients. J Am Soc Hypertens, 2014, 8(10): 693-698.
44.	Wyman R A, Keevil J G, Busse K L, et al. Is the ankle-brachial index a useful screening test for subclinical atherosclerosis in asymptomatic, middle-aged adults?. World Med J, 2006, 105(6): 50-54.
45.	Fowkes F G, Murray G D, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA, 2008, 300(2): 197-208.
46.	Su H M, Lin T H, Hsu P C, et al. Association of interarm systolic blood pressure difference with atherosclerosis and left ventricular hypertrophy. PLoS One, 2012, 7(8): e41173.
47.	Blanes J I, Cairols M A, Marrugat J, et al. Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study. Int Angiol, 2009, 28(1): 20-25.

1. Su T C, Chen S Y, Chan C C. Progress of ambient air pollution and cardiovascular disease research in Asia. Prog Cardiovasc Dis, 2011, 53(5): 369-378.
2. Parissis J T, Nikolaou M, Farmakis D A, et al. Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail, 2009, 11(2): 163-169.
3. Chryssanthopoulos S N, Dritsas A, Cokkinos D V. Activity questionnaires; a useful tool in accessing heart failure patients. Int J Cardiol, 2005, 105(3): 294-299.
4. Faller H, Steinbüchel T, Störk S, et al. Impact of depression on quality of life assessment in heart failure. Int J Cardiol, 2010, 142(2): 133-137.
5. Guyatt G H. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol, 1993, 22(4): A185-A191.
6. 梁国才, 张卫. 美国心血管医学现在和未来. 上海预防医学, 1997, 9(8): 353-355.
7. Rankin S L, Briffa T G, Morton A R, et al. A specific activity questionnaire to measure the functional capacity off cardiac patients. Am J Cardiol, 1996, 77(14): 1220-1223.
8. Mittelmark M B, Psaty B M, Rautaharju P M, et al. Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol, 1993, 137(3): 311-317.
9. Booth G L, Kapral M K, Fung K, et al. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet, 2006, 368(9529): 29-36.
10. Bazzano L A, Gu Dongfeng, Whelton M R, et al. Body mass index and risk of stroke among Chinese men and women. Ann Neurol, 2010, 67(1): 11-20.
11. Lanas F, Avezum A, Bautista L E, et al. Risk factors for acute myocardial infarction in Latin America. Circulation, 2007, 115(9): 1067-1074.
12. Wang Hongwei, Cao Jie, Li Jianxin, et al. Blood pressure, body mass index and risk of cardiovascular disease in Chinese men and women. BMC Public Health, 2010, 10(1): 189.
13. Chobanian A V, Bakris G L, Black H R, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Acc Curr J Rev, 2003, 12(3): 31-32.
14. Magdás A, Benedek I, Belényi B, et al. The relationship between blood pressure variability and cardiovascular risk factors in patients with primary hypertension. Acta Medica Marisiensis, 2015, 61(1): 31-33.
15. Chowdhury E K, Owen A, Krum H, et al. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens, 2014, 32(3): 525-533.
16. Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy novelty and significance. Hypertension, 2014, 64(5): 989-996.
17. Gordon D J, Probstfield J L, Garrison R J, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 1989, 79(1): 8-15.
18. Bai Yuntao, Sun Qinghua. Fine particulate matter air pollution and atherosclerosis: Mechanistic insights. Biochimica et Biophysica Acta-General Subjects, 2016, 1860(12, SI): 2863-2868.
19. Yang Wenying, Lu Juming, Weng Jianping, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12): 1090-1101.
20. Akhuemonkhan E, Lazo M. Association between family history of diabetes and cardiovascular disease and lifestyle risk factors in the United States population: The 2009-2012 National Health and Nutrition Examination Survey. Prev Med, 2017, 96: 129-134.
21. Cordero A, Alegria E. Sex differences and cardiovascular risk. Heart, 2006, 92(2): 145-146.
22. Taylor M K, Larson G E, Lauby M D H, et al. Sex differences in cardiovascular and subjective stress reactions: prospective evidence in a realistic military setting. Stress, 2014, 17(1): 70-78.
23. Reynolds K, Lewis B, Nolen J D, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA, 2003, 289(5): 579-588.
24. Bazzano L A, Gu Dongfeng, Reynolds K, et al. Alcohol consumption and risk for stroke among Chinese men. Ann Neurol, 2007, 62(6): 569-578.
25. Chen Wei. Relationship between smoking and cardiovascular disease mortality, all-cause mortality in hypertension patients: a prospective cohort study. Pract J Cardiac Cerebr Pneum Vasc Dis, 2015, 23(11): 5-9.
26. Jia G X, Yu J M, Lin F L, et al. The relationship between smoking status and cardiovascular risk stratification in hypertensive patients. Chin J Hypertens, 2013, 21(4): 340-345.
27. Gu Dongfeng, Kelly T N, WU Xigui, et al. Mortality attributable to smoking in China. N Engl J Med, 2009, 360(2): 150-159.
28. 李迅. 心血管危险因素控制和心血管病的预防. 中西医结合心血管病电子杂志, 2015, 3(2): 130-131.
29. Vornanen M, Konttinen H, Kääriäinen H, et al. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression. Prev Med, 2016, 90: 177-183.
30. Shao G H, Zhang R L. Study of sports and health guidelines for graduate students. J Wuhan Institute of Physical Education, 2005, 39(9): 61-64.
31. 王国军. 健康管理理念下公务员体质健康评价系统的研究与应用. 上海: 上海体育学院, 2013.
32. Wang Bing, Xie Hongli, Ren Hongyang, et al. Application of AHP, TOPSIS, and TFNs to plant selection for phytoremediation of petroleum-contaminated soils in shale gas and oil fields. J Clean Prod, 2019, 233: 13-22.
33. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the managementof arterial hypertension. Eur Heart J, 2018, 39: 3021-3104.
34. Weber M A, Schiffrin E L, White W B, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens, 2014, 32(1): 3-15.
35. Clark C E, Taylor R S, Shore A C, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet, 2012, 379(9819): 905-914.
36. Clark C E, Taylor R S, Shore A C, et al. Interarm blood pressure difference and vascular disease–authors'reply. Lancet, 2012, 380(9836): 24-25.
37. Cao Kaiwu, Xu Jingsong, Qing Shangguan, et al. Association of an inter-arm systolic blood pressure difference with all-cause and cardiovascular mortality: An updated meta-analysis of cohort studies. Int J Cardiol, 2015, 189: 211-219.
38. Clark C E, Campbell J L, Powell R J. The interarm blood pressure difference as predictor of cardiovascular events in patients with hypertension in primary care: cohort study. J Hum Hypertens, 2007, 21(8): 633-638.
39. Sheng C S, Liu M, Zeng W F, et al. Four-limb blood pressure as predictors of mortality in elderly Chinese novelty and significance. Hypertension, 2013, 61(6): 1155-1160.
40. Chen S C, Chang J M, Tsai Y C, et al. Association of interleg BP difference with overall and cardiovascular mortality in hemodialysis. Clin J Am Soc Nephrol, 2012, 7(10): 1646-1653.
41. Su H M, Lin T H, Hsu P C, et al. Association of interankle systolic blood pressure difference with peripheral vascular disease and left ventricular mass index. Am J Hypertens, 2014, 27(1): 32-37.
42. Clark C E, Campbell J L, Powell R J, et al. The interarm blood pressure difference and peripheral vascular disease: cross-sectional study. Fam Pract, 2007, 24(5): 420-426.
43. Cao Kaiwu, Xu Jinsong, Sun Hanjun, et al. The variability of ankle-arm blood pressure difference and ankle-brachial index in treated hypertensive patients. J Am Soc Hypertens, 2014, 8(10): 693-698.
44. Wyman R A, Keevil J G, Busse K L, et al. Is the ankle-brachial index a useful screening test for subclinical atherosclerosis in asymptomatic, middle-aged adults?. World Med J, 2006, 105(6): 50-54.
45. Fowkes F G, Murray G D, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA, 2008, 300(2): 197-208.
46. Su H M, Lin T H, Hsu P C, et al. Association of interarm systolic blood pressure difference with atherosclerosis and left ventricular hypertrophy. PLoS One, 2012, 7(8): e41173.
47. Blanes J I, Cairols M A, Marrugat J, et al. Prevalence of peripheral artery disease and its associated risk factors in Spain: The ESTIME Study. Int Angiol, 2009, 28(1): 20-25.

Journal of Biomedical Engineering

Research on the cardiovascular function evaluation system based on noninvasive detection indices

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content